Institution statistics

STATENS SERUM INSTITUT - Denmark 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Networking Rank (Reputation):900-1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):800-900
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):900-1000
Networking Rank (Reputation):900-1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Total Project Funding:200-300
Networking Rank (Reputation):500-600
Partner Constancy:400-500
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Total Project Funding:400-500
Networking Rank (Reputation):600-700
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:400-500
Total Project Funding:600-700
Networking Rank (Reputation):600-700
Partner Constancy:200-300
Project Leadership Index:600-700
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:300-400
Networking Rank (Reputation):200-300
Partner Constancy:400-500
Project Leadership Index:200-300
Diversity Index:500-600
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 95
As coordinator: 8
As participant: 80
Sole participant: 7
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 29.780.501 3.366.583 5
2019 0 20.225.373 1.486.980 4
2018 0 49.944.128 4.050.802 3
2017 6.674.498 45.148.559 3.455.008 1 3
2015 0 25.682.729 2.173.002 2
2014 0 20.817.771 903.750 1
2013 0 13.972.181 636.989 2
2012 100.000 8.962.771 261.400 1 1
2011 3.206.599 47.980.529 1.771.425 2 3
2010 0 26.282.771 3.208.643 5
2009 0 15.924.429 757.843 4
2008 0 7.964.343 529.140 2
2007 500.000 14.958.464 764.658 1 3
2006 1.087.247 48.860.312 3.031.205 2 8
2005 259.484 14.341.281 747.641 1 2
2004 0 63.496.150 2.249.054 7
2003 0 17.249.808 801.635 2
2002 1.371.991 9.741.235 1.453.226 3 9
2001 997.506 4.285.909 813.685 1 4
2000 1.722.813 13.861.732 1.955.322 3 10
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
ISTITUTO SUPERIORE DI SANITA19
HEALTH PROTECTION AGENCY16
INSTITUT PASTEUR15
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE13
NORWEGIAN INSTITUTE OF PUBLIC HEALTH13
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU13
UNIVERSITY COLLEGE LONDON13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD12
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE11
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE10
MEDICAL RESEARCH COUNCIL10
DEPARTMENT OF HEALTH9
KAROLINSKA INSTITUTE9
INSTITUT PASTEUR DE LILLE8
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE8
ROBERT KOCH INSTITUT8
UNIVERSITE LIBRE DE BRUXELLES8
UNIVERSITY OF COPENHAGEN8
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV7
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS7
STICHTING KATHOLIEKE UNIVERSITEIT7
SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL7
UNIVERSITE DE GENEVE7
ACADEMISCH ZIEKENHUIS LEIDEN6
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE6
GLAXOSMITHKLINE BIOLOGICALS6
NATIONAL PUBLIC HEALTH INSTITUTE6
ST GEORGE'S HOSPITAL MEDICAL SCHOOL6
UNIVERSITA DEGLI STUDI DI SIENA6
UNIVERSITY OF HELSINKI6
UPPSALA UNIVERSITET6
COMMISSARIAT A L'ENERGIE ATOMIQUE5
DANMARKS TEKNISKE UNIVERSITET5
FELTALALOI ES KUTATO KOZPONT SZOLGALTATO KFT5
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT5
IDLELYSTAD INSTITUUT VOOR DIERHOUDERIJ EN DIERGEZONDHEID BV5
INSTITUTO DE SALUD CARLOS III5
KING'S COLLEGE LONDON5
NATIONAL INSTITUTE OF PUBLIC HEALTH5
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK5
STICHTING TUBERCULOSIS VACCINE INITIATIVE5
TECHNICAL UNIVERSITY OF DENMARK5
THE UNIVERSITY OF EDINBURGH5
UNIVERSITA DEGLI STUDI DI MILANO5
UNIVERSITEIT GENT5
WAGENINGEN UNIVERSITY5
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM4
ACADEMISCH ZIEKENHUIS GRONINGEN4
ARMAUER HANSEN RESEARCH INSTITUTE4
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES4
GENOME RESEARCH4
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE4
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE4
INSTITUTE OF HEALTH CARLOS III4
INSTITUTO NACIONAL DE SAUDE DR RICARDO JORGE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
NATIONAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENT4
SCLAVO VACCINES ASSOCIATION4
TEAGASC AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY4
TERVEYDEN JA HYVINVOINNIN LAITOS4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
THE QUEEN'S UNIVERSITY OF BELFAST4
THE UNIVERSITY OF MILANO4
UNIVERSIDAD COMPLUTENSE DE MADRID4
UNIVERSIDAD DE ZARAGOZA4
UNIVERSITAET ZUERICH4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
UNIVERSITAT DE BARCELONA4
UNIVERSITY OF ABERDEEN4
UNIVERSITY OF SURREY4
UNIVERSITY OF ZURICH4
UNIVERZA V LJUBLJANI4
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS3
AGRICULTURAL UNIVERSITY OF ATHENS3
ASTON UNIVERSITY3
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
ERASMUS UNIVERSITEIT ROTTERDAM3
FOLKHALSOMYNDIGHETEN3
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
GOETEBORGS UNIVERSITET3
HOSPICES CANTONAUX CHUV3
INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER3
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT3
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA3
LEIDEN UNIVERSITY3
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER3
MEDIZINISCHE UNIVERSITAT GRAZ3
MINISTERIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT3
NOFIMA MAT AS3
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE3
PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH3
PUBLIC HEALTH LABORATORY SERVICE3
STATENS VETERINAERMEDICINSKA ANSTALT3
STOCKHOLMS UNIVERSITET3
THE ROYAL VETERINARY COLLEGE3
THE SECRETARY OF STATE FOR ENVIRONMENT FOOD AND RURAL AFFAIRS3
Constancy:

Total number of partners:1476

Partner loyalty:
Frequent Partner: (> 2 projects): 585
Rare Partner: 891

Frequent / Rare Partner Ratio: 0.66

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES62
RTD HORIZONTAL TOPICS43
SOCIAL AND ECONOMIC CONCERNS39
PROTECTING MAN AND HIS ENVIRON25
AGRICULTURE AND MARINE RESOURC8
INDUSTRY AND TECHNOLOGY3
MEASUREMENTS AND STANDARDS2

Project overview:

Start dateProjectacronymrolefundingpartners
2020-06-01DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE TRANSVAC-DSparticipant1.879.21625
2020-04-01Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits CORONADXparticipant2.970.2098
2020-04-01Nanobodies and antibodies against 2019-nCoV CoroNAbparticipant2.771.6584
2020-01-01Human Exposome Assessment Platform HEAPparticipant11.996.51511
2020-01-01FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA FAIRparticipant10.162.90411
2019-11-01Collaboration for Prevention and Treatment of MDR Bacterial Infections COMBINEparticipant8.000.00011
2019-10-01A nanovaccine Approach for the treatment of Pancreatic Cancer PAVEparticipant4.023.61715
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2019-01-01Novel vaccine vectors to resist pathogen challenge VacPathparticipant2.701.8748
2018-07-01Effects of Prenatal Exposure to Acrylamide on Health: Prospective Biomarker-Based Studies CHIPSparticipant1.499.5313
2018-01-01Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards. One Health EJPparticipant44.999.00042
2018-01-01Combatting Antimicrobial Resistance Training Network CARTNETparticipant3.445.59712
2017-05-01European Vaccine Research and Development Infrastructure TRANSVAC2participant10.599.99326
2017-03-01Developing a Chlamydia Trachomatis vaccine TracVaccoordinator6.674.4984
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01Optimizing a deployable high efficacy malaria vaccine OptiMalVaxparticipant20.050.44118
2015-05-01I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly I-MOVE-plusparticipant7.482.72925
2015-01-01TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development TBVAC2020participant18.200.00044
2014-12-01COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe COMPAREparticipant20.817.77129
2013-10-01Universal Influenza Vaccines Secured UNISECparticipant5.972.18112
2013-02-01BBMRI - Large Prospective Cohorts BBMRI-LPCparticipant8.000.00030
2012-08-01Comprehensive molecular analysis and differentiation of the eukaryotic microbiota in faecal samples from human cohorts to establish the role of intestinal eukaryotes in health and disease GUT18Scoordinator100.0001
2012-02-01Long-term effects of early nutrition on later health EarlyNutritionparticipant8.962.77138
2011-12-01Preserving old antibiotics for the future : assessment of clinical efficacy by a pharmacokinetic/pharmacodynamic approach to optimize effectiveness and reduce resistance for off-patent antibiotics AIDAparticipant5.999.86019
2011-10-01Resistance in Gram-Negative Organisms: Studying Intervention Strategies R-GNOSISparticipant11.999.99924
2011-10-01Advanced Immunization Technologies ADITECparticipant29.980.67052
2011-03-01Optimising the impact and cost-effectiveness of child health intervention programmes of vaccines and micronutrients in low-income countries optimunisecoordinator2.999.9708
2011-01-01The T cell immune response against latent infection with Mycobacterium tuberculosis TILIMcoordinator206.6291
2010-11-01European Research Infrastructure on Highly Pathogenic Agents ERINHAparticipant3.600.00025
2010-04-01Predicting antibiotic resistance PARparticipant6.000.00012
2010-03-01Clinical development of a Pfs48/45-based malaria transmission blocking vaccine REDMALparticipant2.999.9986
2010-01-01Discovery and preclinical development of new generation tuberculosis vaccines NEWTBVACparticipant11.996.73035
2010-01-01Child health intervention interactions in low-income countries CHILICparticipant1.686.0431
2009-04-01Initiative on optimizing malaria vaccine lab assays evaluation OPTIMALVACparticipant1.000.00014
2009-02-01Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges INYVAXparticipant932.33510
2009-01-01Pan-European network for the study and clinical management of drug resistant tuberculosis TB PAN-NETparticipant10.998.27032
2009-01-01Preventing community and nosocomial spread and infection with MRSA ST 398 - instruments for accelerated control and integrated risk management of antimicrobial resistance PILGRIMparticipant2.993.82412
2008-05-01Establishment, strategy and initial activities of the tuberculosis vaccine initiative : coordination of european efforts with global research initiatives ESI-TBVIparticipant429.6015
2008-02-01Next generation HIV-1 immunogens inducing broadly reactive neutralising antibodies NGINparticipant7.534.74217
2007-02-01Approaches to control multi-resistant enterococci: studies on molecular ecology, horizontal gene transfer, fitness and prevention ACEparticipant3.148.00012
2007-02-01Pathogenic Escherichia coli Network PENparticipant810.65735
2007-01-01Cross-Sectorial observations of threat perceptions and research priorities in European Biological Homeland Security CORPScoordinator500.0002
2007-01-01Improved bio-traceability of unintended microorganisms and their substances in food and feed chains BIOTRACE IPparticipant10.999.80748
2006-12-01European network for harmonisation of malaria vaccine development EURHAVACcoordinator259.9341
2006-12-01Development of a specific serological kit for the diagnosis of TB SERO-TBcoordinator827.3134
2006-12-01The European malaria vaccine development association EMVDAparticipant13.500.00016
2006-07-01BIOlogical agents: Strengthening the Adequate response to deliberate releases by the establishment of a Framework European-wide. BIOSAFEparticipant801.00010
2006-06-01Development of improved tools for detection of paratuberculosis in livestock, M.paratuberculosis in food and for the assessment of the risk of human exposure PARATBTOOLSparticipant3.940.00028
2006-03-01Concerted action on seroconversion to AIDS and death in Europe CASCADEparticipant1.700.00025
2006-03-01European Cohort coordinating network on HIV drug resistance EUROPEHIVRESISTANCEparticipant1.499.33637

overview shows latest 50 from 95 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • STATENS SERUM INSTITUT

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum